These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 13280621)

  • 21. [A new drug, pyridostigmine, in therapy of myasthenia].
    FURTADO D
    J Med (Oporto); 1954 Apr; 23(586):953-9. PubMed ID: 13162673
    [No Abstract]   [Full Text] [Related]  

  • 22. WIN 8077 in treatment of myasthenia gravis; use of N,N'-bis (2-diethylaminoethyl) oxamide bis-2-chlorobenzyl chloride in fifty patients.
    SCHWAB RS; MARSHALL CK; TIMBERLAKE W
    J Am Med Assoc; 1955 Jun; 158(8):625-8. PubMed ID: 14381226
    [No Abstract]   [Full Text] [Related]  

  • 23. [Initial experiments with pyridostigmine (mestinon Roche)].
    RADERMECKER MA
    Acta Neurol Psychiatr Belg; 1955 Apr; 55(4):356-63. PubMed ID: 13248495
    [No Abstract]   [Full Text] [Related]  

  • 24. Mestinon in myasthenia gravis; preliminary report.
    TETHER JE
    Dis Nerv Syst; 1954 Aug; 15(8):227-31. PubMed ID: 13191272
    [No Abstract]   [Full Text] [Related]  

  • 25. [Case of myasthenia gravis].
    KATILA O; KIVALO E
    Duodecim; 1955; 71(4):605-10. PubMed ID: 14391241
    [No Abstract]   [Full Text] [Related]  

  • 26. [Further progress in therapy of myasthenic syndrome].
    STRUPPLER A
    Med Monatsschr; 1953 Jul; 7(7):428-32. PubMed ID: 13098853
    [No Abstract]   [Full Text] [Related]  

  • 27. Urecholine in myasthenia gravis.
    SCHWARZ H
    Can Med Assoc J; 1955 Mar; 72(5):346-51. PubMed ID: 14352096
    [No Abstract]   [Full Text] [Related]  

  • 28. [First therapeutic results with mytelase (mysuran, win 8077) in myasthenia].
    DESMEDT JE
    Acta Neurol Psychiatr Belg; 1957 Feb; 57(2):94-103. PubMed ID: 13424193
    [No Abstract]   [Full Text] [Related]  

  • 29. Progress report on mestinon bromide (pyridostigmine bromide).
    OSSERMAN KE
    Am J Med; 1955 Nov; 19(5):737-9. PubMed ID: 13268474
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical evaluation of ambenonium (mysuran) chloride.
    WESTERBERG MR
    AMA Arch Neurol Psychiatry; 1956 Jan; 75(1):91-4. PubMed ID: 13275166
    [No Abstract]   [Full Text] [Related]  

  • 31. [Myasthenia and mediastinal tumor; favorable effect of a new anti-myasthenic preparation].
    SUTTER JM; LARMANDE AM
    Rev Otoneuroophtalmol; 1953; 25(4):231-4. PubMed ID: 13112901
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trials with a new anti-myasthenic drug: N, N'-bis (2-diethylaminoethyl)-oxamide bis-2-chlorobenzyl chloride (Win 8077)].
    ALAJOUANINE T; CASTAIGNE P; BOURGUIGNON A; CAMBIER J
    Therapie; 1958; 13(5):799-804. PubMed ID: 13625192
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myasthenia gravis].
    Stackhouse J
    Infirm Can; 1974 Mar; 16(3):28-33. PubMed ID: 4493945
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of 3-hydroxy phenyl-dimethylethylammonium chloride (tensilon) in myasthenia gravis.
    WESTERBERG MR; MAGEE KR; SHIDEMAN FE
    Med Bull (Ann Arbor); 1951 Sep; 17(9):311-6. PubMed ID: 14893613
    [No Abstract]   [Full Text] [Related]  

  • 35. Seronegative myasthenia gravis and human immunodeficiency virus infection: response to intravenous gamma globulin and prednisone.
    Strong J; Zochodne DW
    Can J Neurol Sci; 1998 Aug; 25(3):254-6. PubMed ID: 9706730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preliminary results with armin (ethyl-ethoxy phosphoryl p-nitrophenolate) in myasthenia gravis].
    VOJVODIC V; GRBESA B; STEVANOVIC M; BINENFELD Z; GAZIVODA N; BARYLA K; BOZIC V
    Vojnosanit Pregl; 1960 Nov; 17():1167-70. PubMed ID: 13781940
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of x-ray irradiation of the thymus gland in myasthenia gravis].
    Raczkiewicz J
    Neurol Neurochir Pol; 1970; 4(3):357-9. PubMed ID: 5455386
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current trends in medical and surgical treatment of myasthenia gravis with persistence of the thymus and long-term results of some operated cases].
    Sunseri S; Sottosanti M; Spinelli P
    Arch Chir Torac Cardiovasc; 1970; 26(1):19-34. PubMed ID: 5477673
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of juvenile myasthenia gravis.
    Ionita CM; Acsadi G
    Pediatr Neurol; 2013 Feb; 48(2):95-104. PubMed ID: 23337001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic value of new antimyasthenia drugs according to clinical and electromyographic aspects].
    EMERYK B; BIEZANSKI W
    Neurol Neurochir Psychiatr Pol; 1959; 9():471-83. PubMed ID: 13820172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.